These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7178131)

  • 21. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of galactose-induced cataractogenesis in rats by salvianolic acid A].
    Du GH; Qiu Y; Tian YE; Zhang JT
    Yao Xue Xue Bao; 1995; 30(8):561-6. PubMed ID: 8571774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Cataract Potential of Heliotropium indicum Linn on Galactose-Induced Cataract in Sprague-Dawley Rats.
    Kyei S; Koffuor GA; Ramkissoon P; Abu EK; Sarpong JF
    Curr Eye Res; 2017 Mar; 42(3):394-401. PubMed ID: 27419531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts.
    Creighton MO; Ross WM; Stewart-DeHaan PJ; Sanwal M; Trevithick JR
    Exp Eye Res; 1985 Feb; 40(2):213-22. PubMed ID: 3979462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of taurine in the crystalline lens of vertebrate species and in cataractogenesis.
    Gupta K; Mathur RL
    Exp Eye Res; 1983 Oct; 37(4):379-84. PubMed ID: 6641821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
    Unakar NJ; Harries W; Tsui J
    Exp Eye Res; 1985 Jan; 40(1):117-26. PubMed ID: 3920063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of c-myc protooncogene in rat lens cells during development, maturation and reversal of galactose cataracts.
    Wen Y; Shu S; Unakar NJ; Bekhor I
    Mol Cell Biochem; 1992 May; 112(1):73-9. PubMed ID: 1513336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited proteolysis of MP26 in lens fiber plasma membranes of the galactose-induced cataract in the rat.
    Alcala J; Unakar NJ; Katar M; Tsui JY
    Curr Eye Res; 1986 Sep; 5(9):697-703. PubMed ID: 3533434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative antioxidant defense against oxidative challenge in galactose-induced cataractogenesis in Wistar rats.
    Raju TN; Kumar CS; Kanth VR; Ramana BV; Reddy PU; Suryanarayana P; Reddy GB
    Indian J Exp Biol; 2006 Sep; 44(9):733-9. PubMed ID: 16999028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A rat experimental posterior subcapsular cataract model resembling human diabetic cataract].
    Nakamoto S; Terubayashi H; Akagi Y; Miyamoto Y; Tutumi M; Yokoi N; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):161-5. PubMed ID: 3389258
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes of urea-soluble and intrinsic membrane proteins in rat lenses during the formation of galactose cataract.
    Zhao HR; Ren XH
    Ophthalmic Res; 1992; 24(5):285-8. PubMed ID: 1475076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ; Tsui JY; Johnson MJ
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS; Srinivasan K
    Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of glutathione and taurine concentrations in lenses of rat eyes induced by galactose-cataract formation or ageing.
    Kasuya M; Itoi M; Kobayashi S; Sunaga H; Suzuki KT
    Exp Eye Res; 1992 Jan; 54(1):49-53. PubMed ID: 1541340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of galactose-induced cataractogenesis by troglitazone, a new antidiabetic drug with an antioxidant property, in rat lens culture.
    Yokoyama T; Yoshida Y; Inoue T; Horikoshi H
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):73-83. PubMed ID: 10048350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to produce cataracts in rats with galactitol diet.
    Wilson WA
    Am J Ophthalmol; 1969 Feb; 67(2):224-9. PubMed ID: 5764639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.